102(top 1%)
papers
2.4K(top 1%)
citations
28(top 1%)
h-index
47(top 1%)
g-index
121
all documents
2.8K
doc citations
741
citing journals

Top Articles

#TitleJournalYearCitations
1Camrelizumab plus carboplatin and pemetrexed versus chemotherapy alone in chemotherapy-naive patients with advanced non-squamous non-small-cell lung cancer (CameL): a randomised, open-label, multicentre, phase 3 trialLancet Respiratory Medicine,the2021277
2Nivolumab Versus Docetaxel in a Predominantly Chinese Patient Population With Previously Treated Advanced NSCLC: CheckMate 078 Randomized Phase III Clinical TrialJournal of Thoracic Oncology2019260
3Long non-coding RNA UCA1 induces non-T790M acquired resistance to EGFR-TKIs by activating the AKT/mTOR pathway in EGFR-mutant non-small cell lung cancerOncotarget2015144
4Folate Receptor–Positive Circulating Tumor Cell Detected by LT-PCR–Based Method as a Diagnostic Biomarker for Non–Small-Cell Lung CancerJournal of Thoracic Oncology2015105
5Prognostic Significance of Neutrophil Lymphocyte Ratio in Patients with Gastric Cancer: A Meta-AnalysisPLoS ONE201485
6Novel Effector Phenotype of Tim-3+ Regulatory T Cells Leads to Enhanced Suppressive Function in Head and Neck Cancer PatientsClinical Cancer Research201882
7T790M mutation is associated with better efficacy of treatment beyond progression with EGFR-TKI in advanced NSCLC patientsLung Cancer201481
8Microarray expression profile of long non-coding RNAs in EGFR-TKIs resistance of human non-small cell lung cancerOncology Reports201580
9Efficacy and Biomarker Analysis of Camrelizumab in Combination with Apatinib in Patients with Advanced Nonsquamous NSCLC Previously Treated with ChemotherapyClinical Cancer Research202179
10Correlation of long non-coding RNA H19 expression with cisplatin-resistance and clinical outcome in lung adenocarcinomaOncotarget201770
11Peripheral Blood for Epidermal Growth Factor Receptor Mutation Detection in Non-Small Cell Lung Cancer PatientsTranslational Oncology201468
12Clinical features and therapeutic options in non‐small cell lung cancer patients with concomitant mutations of EGFR, ALK, ROS1, KRAS or BRAFCancer Medicine201959
13Symptom and Quality of Life Improvement in LUX-Lung 6: An Open-Label Phase III Study of Afatinib Versus Cisplatin/Gemcitabine in Asian Patients With EGFR Mutation-Positive Advanced Non–small-cell Lung CancerJournal of Thoracic Oncology201555
14Long non-coding RNA UCA1 promotes lung cancer cell proliferation and migration via microRNA-193a/HMGB1 axisBiochemical and Biophysical Research Communications201855
15Frequency of the acquired resistant mutation T790 M in non-small cell lung cancer patients with active exon 19Del and exon 21 L858R: a systematic review and meta-analysisBMC Cancer201853
16Analysis of Driver Mutations in Female Non-Smoker Asian Patients with Pulmonary AdenocarcinomaCell Biochemistry and Biophysics201252
17Prognostic role of C-reactive protein in prostate cancer: a systematic review and meta-analysisAsian Journal of Andrology201451
18Differences of osteoblastic bone metastases and osteolytic bone metastases in clinical features and molecular characteristicsClinical and Translational Oncology201539
19Current progress and mechanisms of bone metastasis in lung cancer: a narrative reviewTranslational Lung Cancer Research202139
20Elevated TRIM23 expression predicts cisplatin resistance in lung adenocarcinomaCancer Science202038
21Afatinib versus methotrexate as second-line treatment in Asian patients with recurrent or metastatic squamous cell carcinoma of the head and neck progressing on or after platinum-based therapy (LUX-Head & Neck 3): an open-label, randomised phase III trialAnnals of Oncology201937
22Comparison of cross-platform technologies for EGFR T790M testing in patients with non-small cell lung cancerOncotarget201735
23High-Level mRNA of Excision Repair Cross-Complementation Group 1 Gene Is Associated With Poor Outcome of Platinum-Based Doublet Chemotherapy of Advanced Nonsmall Cell Lung Cancer PatientsCancer Investigation201034
24Association between polymorphisms of DNA repair genes and survival of advanced NSCLC patients treated with platinum-based chemotherapyLung Cancer201234
25A multicenter, randomized trial comparing efficacy and safety of paclitaxel/capecitabine and cisplatin/capecitabine in advanced gastric cancerGastric Cancer201833
26STAT3 Contributes To Oncolytic Newcastle Disease Virus-Induced Immunogenic Cell Death in Melanoma CellsFrontiers in Oncology201933
27SHP2 negatively regulates HLA-ABC and PD-L1 expression via STAT1 phosphorylation in prostate cancer cellsOncotarget201733
28Cell block samples from malignant pleural effusion might be valid alternative samples for anaplastic lymphoma kinase detection in patients with advanced non‐small‐cell lung cancerHistopathology201532
29Elevated Glutathione Peroxidase 2 Expression Promotes Cisplatin Resistance in Lung AdenocarcinomaOxidative Medicine and Cellular Longevity202032
30A case of lung adenocarcinoma harboring exon 19 EGFR deletion and EML4-ALK fusion geneLung Cancer201331
31JAK2 inhibitor blocks the inflammation and growth of esophageal squamous cell carcinoma in vitro through the JAK/STAT3 pathwayOncology Reports201529
32Enhanced immunofluorescence detection of a protein marker using a PAA modified ZnO nanorod array-based microfluidic deviceNanoscale201828
33Current small cell lung cancer treatment in ChinaThoracic Cancer201526
34Targeting STAT3 enhances NDV‐induced immunogenic cell death in prostate cancer cellsJournal of Cellular and Molecular Medicine202024
35HOTAIR induces EGFR-TKIs resistance in non-small cell lung cancer through epithelial-mesenchymal transitionLung Cancer202021
36Association of XRCC3 and XPD751 SNP with efficacy of platinum-based chemotherapy in advanced NSCLC patientsClinical and Translational Oncology201220
37The association of UGT1A1*6 and UGT1A1*28 with irinotecan-induced neutropenia in Asians: a meta-analysisBiomarkers201420
38A meta-analysis for C-X-C chemokine receptor type 4 as a prognostic marker and potential drug target in hepatocellular carcinomaDrug Design, Development and Therapy201520
39αPD-1-mesoCAR-T cells partially inhibit the growth of advanced/refractory ovarian cancer in a patient along with daily apatinib202120
40Real-world clinical outcomes of neoadjuvant immunotherapy combined with chemotherapy in resectable non-small cell lung cancerLung Cancer202219
41Interleukin-10 Is a Promising Marker for Immune-Related Adverse Events in Patients With Non-Small Cell Lung Cancer Receiving ImmunotherapyFrontiers in Immunology202219
42Mechanisms Behind the Inhibition of Lung Adenocarcinoma Cell by ShikoninCell Biochemistry and Biophysics201418
43Blood α-Tocopherol, γ-Tocopherol Levels and Risk of Prostate Cancer: A Meta-Analysis of Prospective StudiesPLoS ONE201418
44A Renal‐Clearable Activatable Molecular Probe for Fluoro‐Photacoustic and Radioactive Imaging of Cancer BiomarkersSmall202218
45The impact of EGFR exon 19 deletion subtypes on clinical outcomes in non-small cell lung cancerTranslational Lung Cancer Research202017
46Genomic Alterations of NTRK, POLE, ERBB2, and Microsatellite Instability Status in Chinese Patients with Colorectal CancerOncologist202017
47Prognostic Value of Human Equilibrative NucleosideTransporter1 in Pancreatic Cancer Receiving Gemcitabin-Based Chemotherapy: A Meta-AnalysisPLoS ONE201416
48AURA17 study of osimertinib in Asia-Pacific patients (pts) with EGFR T790M-positive advanced non-small cell lung cancer (NSCLC): Updated phase II results including overall survival (OS)Annals of Oncology201814
49CRISPR Screens Identify Essential Cell Growth Mediators in BRAF Inhibitor-resistant MelanomaGenomics, Proteomics and Bioinformatics202014
50The Role of Circulating Tumor DNA in Advanced Non-Small Cell Lung Cancer Patients Treated With Immune Checkpoint Inhibitors: A Systematic Review and Meta-AnalysisFrontiers in Oncology202114